Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumors: initial dosimetry and safety results of the P-PRRT trial

被引：0
|
作者：
Del Prete, Michela [1 ,2 ,3 ,4 ]
Buteau, Francois-Alexandre [1 ,2 ,3 ,4 ]
Beaulieu, Alexis [1 ,2 ,3 ,4 ]
Beauregard, Jean-Mathieu [1 ,2 ,3 ,4 ]
机构：
[1] Univ Laval, Dept Radiol & Nucl Med, Quebec City, PQ, Canada
[2] Univ Laval, Canc Res Ctr, Quebec City, PQ, Canada
[3] Univ Laval, Dept Med Imaging, Div Nucl Med, CHU Quabec, Quebec City, PQ, Canada
[4] Univ Laval, Res Ctr, Oncol Branch, CHU Quabec, Quebec City, PQ, Canada
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
基金：
加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
    Michela Del Prete
    François-Alexandre Buteau
    Frédéric Arsenault
    Nassim Saighi
    Louis-Olivier Bouchard
    Alexis Beaulieu
    Jean-Mathieu Beauregard
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 728 - 742
  • [2] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
    Del Prete, Michela
    Buteau, Francois-Alexandre
    Arsenault, Frederic
    Saighi, Nassim
    Bouchard, Louis-Olivier
    Beaulieu, Alexis
    Beauregard, Jean-Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 728 - 742
  • [3] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: preliminary dosimetry, efficacy and safety results from the P-PRRT trial
    Del Prete, M.
    Arsenault, F.
    Saighi, N.
    Bouchard, L. O.
    Beaulieu, A.
    Buteau, F. A.
    Beauregard, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S60 - S61
  • [4] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
    Del Prete, Michela
    Buteau, Francois-Alexandre
    Beauregard, Jean-Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1490 - 1500
  • [5] Personalized 177Lu-Octreotate Peptide Receptor Radionuclide Therapy (PRRT) Allows a Safe and Significant Increase of Radiation Dose to Neuroendocrine Tumors (NETs)
    Del Prete, M.
    Buteau, F. A.
    Beauregard, J. M.
    NEUROENDOCRINOLOGY, 2016, 103 : 92 - 92
  • [6] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
    Michela Del Prete
    François-Alexandre Buteau
    Jean-Mathieu Beauregard
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1490 - 1500
  • [7] Efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumors of the small intestine
    Sabet, A.
    Dautzenberg, K.
    Haslerud, T.
    Aouf, A.
    Sabet, A.
    Simon, B.
    Mayer, K.
    Biersack, H.
    Ezziddin, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S211 - S211
  • [8] Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
    Michela Del Prete
    Frédéric Arsenault
    Nassim Saighi
    Wei Zhao
    François-Alexandre Buteau
    Anna Celler
    Jean-Mathieu Beauregard
    EJNMMI Physics, 5
  • [9] Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
    Del Prete, M.
    Arsenault, F.
    Saighi, N.
    Zhao, W.
    Buteau, F. A.
    Celler, A.
    Beauregard, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S31 - S31
  • [10] Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
    Del Prete, Michela
    Arsenault, Frederic
    Saighi, Nassim
    Zhao, Wei
    Buteau, Francois-Alexandre
    Celler, Anna
    Beauregard, Jean-Mathieu
    EJNMMI PHYSICS, 2018, 5
12345